on INVENTIVA (EPA:IVA)
Inventiva Announces Temporary Trading Halt on Euronext Paris
On November 13, 2025, Inventiva, a clinical-stage biopharmaceutical company, announced a temporary halt in trading of its ordinary shares on Euronext Paris. This pause, initiated at the company's request, aligns with their public offering of new American Depositary Shares (ADSs) in the United States. The halt allows for confirmation of allocations to investors and pricing announcements regarding the offering. The suspension, effective from the market opening at 9:00 a.m. CET, is expected to lift the same day at 3:30 p.m. CET, coinciding with the anticipated start of ADS trading on the Nasdaq Global Market under the ticker "IVA."
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INVENTIVA news